Market Overview:
The global zidovudine market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of HIV/AIDS, rising demand for better treatment options, and growing awareness about HIV/AIDS. The global zidovudine market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into oral and injectable. The oral segment dominates the global zidovudine market owing to its ease-of-use and lower cost as compared to injectable drugs. On the basis of application, the market is divided into HIV treatment and HIV prevention. The majority share in this category is held by HIV treatment applications due to rising incidence rates across all regions globally.
Product Definition:
Zidovudine is a medication used to prevent and treat HIV/AIDS. It is also used to prevent and treat hepatitis B infection in people with HIV/AIDS. Zidovudine may be used alone or with other medications to treat HIV/AIDS.
Oral:
Oral is a drug delivery route which involves the use of mouth, throat, and digestive system to deliver medications. It can be used for both solid and liquid medications. The most common oral dosage forms are tablets, capsules (pills), powders, solutions (brands), syrups and suspensions.
Injectable:
Zidovudine (Reteplase) is an injectable drug used for the treatment of HIV-1 infection. It was approved by the U.S. FDA in 1999 and by the EMA in 2000 as a first line antiretroviral therapy for HIV-1 infected patients weighing more than 50 kg, with no CD4 count below 200 cells/mm3 and a viral load greater than 500 copies/mL.
Application Insights:
Based on application, the global market is segmented into HIV treatment, HIV prevention and others. The HIV treatment segment dominated the overall market in 2017 owing to increasing prevalence of AIDS and a growing need for effective antiretroviral therapy (ART). According to UNAIDS, there were 37 million people living with AIDS across 36 countries in Africa as of 2016. In addition, according to an article published by TheBody.com in 2018, nearly 30 million people are estimated to be living with undiagnosed symptoms of AIDS worldwide. Therefore, increasing demand for zidovudine is expected to drive growth over the forecast period.
The use of zidovudine for preventing transmission from mother-to-child during breastfeeding was one of the key factors that led towards its dominance in 2017 owing to high effectiveness against vertical transmission compared with other available options such as lamivudine.
Regional Analysis:
North America dominated the global market in 2017. The presence of key manufacturers and suppliers, along with high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region, are some factors attributing to its largest share. Moreover, increasing cases of HIV/AIDS and growing demand for highly effective treatment options are expected to drive the regional market further.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising prevalence rates of HIV/AIDS as well as increasing government initiatives pertaining towards prevention programs targeting at-risk populations such as homosexuals and injecting drug users (IDUs). In addition, favorable government policies aimed at improving access & affordability related issues pertaining towards antiretroviral drugs will also boost revenue generation capacity over the coming years.
Growth Factors:
- Increasing incidence of HIV/AIDS: The number of people affected by HIV is increasing at an alarming rate, which is expected to drive the demand for zidovudine in the coming years.
- Rising awareness about HIV and its treatment: There has been a rise in the awareness about HIV and its treatment options in recent years. This is likely to boost the demand for zidovudine in the near future.
- Growing number of clinical studies on zidovudine: A growing number of clinical studies are being conducted on zidovudine, which is likely to increase its adoption rates in the coming years.
- Availability of generic versions: The availability of generic versions of zidovudine at affordable prices is expected to boost its adoption rates among patients worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Zidovudine Market Research Report
By Type
Oral, Injectable
By Application
HIV Treatment, HIV Prevention
By Companies
Pharma Waldhof GmbH (Aceto Coporation), Beike Biology Pharmacy
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Zidovudine Market Report Segments:
The global Zidovudine market is segmented on the basis of:
Types
Oral, Injectable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
HIV Treatment, HIV Prevention
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pharma Waldhof GmbH (Aceto Coporation)
- Beike Biology Pharmacy
Highlights of The Zidovudine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Injectable
- By Application:
- HIV Treatment
- HIV Prevention
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Zidovudine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Zidovudine is a medication used to treat HIV infection. It works by stopping the virus from multiplying in the body. Zidovudine may also help prevent new infections from happening.
Some of the major companies in the zidovudine market are Pharma Waldhof GmbH (Aceto Coporation), Beike Biology Pharmacy.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Zidovudine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Zidovudine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Zidovudine Market - Supply Chain
4.5. Global Zidovudine Market Forecast
4.5.1. Zidovudine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Zidovudine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Zidovudine Market Absolute $ Opportunity
5. Global Zidovudine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Zidovudine Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Injectable
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Zidovudine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Zidovudine Market Size and Volume Forecast by Application
6.3.1. HIV Treatment
6.3.2. HIV Prevention
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Zidovudine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Zidovudine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Zidovudine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Zidovudine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Zidovudine Demand Share Forecast, 2019-2026
9. North America Zidovudine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Zidovudine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Zidovudine Market Size and Volume Forecast by Application
9.4.1. HIV Treatment
9.4.2. HIV Prevention
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Zidovudine Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Injectable
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Zidovudine Demand Share Forecast, 2019-2026
10. Latin America Zidovudine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Zidovudine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Zidovudine Market Size and Volume Forecast by Application
10.4.1. HIV Treatment
10.4.2. HIV Prevention
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Zidovudine Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Injectable
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Zidovudine Demand Share Forecast, 2019-2026
11. Europe Zidovudine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Zidovudine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Zidovudine Market Size and Volume Forecast by Application
11.4.1. HIV Treatment
11.4.2. HIV Prevention
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Zidovudine Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Injectable
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Zidovudine Demand Share, 2019-2026
12. Asia Pacific Zidovudine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Zidovudine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Zidovudine Market Size and Volume Forecast by Application
12.4.1. HIV Treatment
12.4.2. HIV Prevention
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Zidovudine Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Injectable
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Zidovudine Demand Share, 2019-2026
13. Middle East & Africa Zidovudine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Zidovudine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Zidovudine Market Size and Volume Forecast by Application
13.4.1. HIV Treatment
13.4.2. HIV Prevention
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Zidovudine Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Injectable
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Zidovudine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Zidovudine Market: Market Share Analysis
14.2. Zidovudine Distributors and Customers
14.3. Zidovudine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Pharma Waldhof GmbH (Aceto Coporation)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Beike Biology Pharmacy
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook